Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
52 pending office actions • 44 clients • 50 examiners • 31 art units • 0 of 52 (0%) have an AI response strategy ready
Silvia Salvadori, P.C. focuses on the Biotechnology & Pharmaceuticals technology area, with 1051 career applications. The firm has achieved a resolved allowance rate pct of 82.32. Currently, there are 44 pending office actions in its docket. The 1051 career applications show a foundation of experience in biotechnology patent law.
The average office actions per allowance for this profile is 3.93. This figure indicates that applications in the Biotechnology & Pharmaceuticals field often require multiple rounds of prosecution to reach an allowance. The 82.32 resolved allowance rate pct reflects a degree of success for the 1051 career applications managed by the firm. With 44 pending office actions, the firm is actively managing its current workload. These data points together illustrate the firm's historical performance and its current status within its primary technology area.
Based on the USPTO statutory response window for each pending office action. 21 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 21 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (4%) |
| §103 only | 15 (29%) |
| §112 only | 3 (6%) |
| Double-patenting only | 1 (2%) |
| Double-patenting + other | 6 (12%) |
| Multi-statute (no §101) | 25 (48%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| POLLEY, CHRISTOPHER M | 2 | 72.9% | +26.4% |
| BEKKER, KELLY JO | 2 | 16.7% | +35.4% |
| VAN KREUNINGEN, KYRA MELOR | 1 | 100.0% | +0.0% |
| WILLIAMS, KEITH RICHARD | 1 | 50.0% | +0.0% |
| GOUGH, TIFFANY MAUREEN | 1 | 31.6% | +46.8% |
| ALAOUIE, ALI MUSTAFA | 1 | — | — |
| MAYHEW, BRADLEY SCOTT | 1 | — | — |
| LEFF, STEVEN N | 1 | 41.3% | +7.9% |
| RAO, SAVITHA M | 1 | 60.7% | +30.2% |
| HOLT, ANDRIAE M | 1 | 49.3% | +22.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17905646 | BLOOD PREPARATION USEFUL FOR WOUND HEALING AND TISSUE REGENERATION | MELLER, MICHAEL V | 78d overdue |
| 17904895 | HYBRID COSMETIC PRODUCT CONSISTING OF CREAMY COMPACT POWDER | OLSEN, KAELEIGH ELIZABETH | 78d overdue |
| 18040525 | RETANNING AND FATLIQUORING COMPOSITIONS COMPRISING A HEMP OIL DERIVATIVE | KHAN, AMINA S | 46d overdue |
| 17609416 | FERTILIZING COMPOSITION COMPRISING A GLASS MATRIX | SILVA RAINBOW, HEATHER ELISE | 42d overdue |
| 18246607 | RECOMBINANT YEAST FOR THE PRODUCTION OF OLIGOPEPTIDE | NOAKES, SUZANNE MARIE | 18d overdue |
| 17757455 | SYNOVIAL FLUID SUBSTITUTES | WAX, ROBERT A | 7d |
| 17798218 | BIO-BASED BINDERS AND METHODS FOR PRODUCING SAME | TOLIN, MICHAEL A | 13d |
| 18719160 | PROBIOTIC COMPOSITIONS AND THEIR USE IN MODULATING ALLERGY-TYPE INFLAMMATORY ACTIVITY | CELSA, BENNETT M | 20d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18561818 | FILLER FOR POLYMERIC COMPOSITIONS DERIVED FROM CITRUS PROCESSING AND/OR PRESSING WASTE | POLLEY, CHRISTOPHER M | 61d |
| 19053630 | WATER-BASED INKS FOR DIGITAL PRINTING ON EDGES | POLLEY, CHRISTOPHER M | — |
| 18865784 | LACTICASEIBACILLUS PARACASEI DG(R) CNCM I-1572 DSM 34154 FOR USE IN A METHOD OF TREATING DYSBIOSIS IN PATIENTS WITH IBS | GOUGH, TIFFANY MAUREEN | — |
| 18863428 | CONFECTIONERY PRODUCT RESISTANT TO HIGH TEMPERATURES | BEKKER, KELLY JO | — |
| 18835362 | QUERCETIN-BASED COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF OCULAR AFFECTIONS | RAO, SAVITHA M | — |
| 18832515 | COMPOSITION CONTAINING NERO DI TROIA POMACE EXTRACT | HOLT, ANDRIAE M | — |
| 18687442 | METHOD FOR INCORPORATING FAT-SOLUBLE INGREDIENT INTO COMESTIBLE PRODUCT, AND PRODUCT RESULTING THEREFROM | BEKKER, KELLY JO | — |
| Art Unit | Apps |
|---|---|
| 1656 | 3 |
| 1792 | 2 |
| 1614 | 2 |
| 1623 | 2 |
| 1655 | 2 |
| 1693 | 2 |
| 1619 | 2 |
| 1663 | 1 |
| 1613 | 1 |
| 1651 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19053630 | WATER-BASED INKS FOR DIGITAL PRINTING ON EDGES | Inkgenio S.R.L | POLLEY, CHRISTOPHER M | §102§103 | Non-Final OA | — | Pending | Feb 14, 2025 | |
| 19101414 | NON-AQUEOUS UV/LED DIGITAL INKS FOR PRINTING FLEXIBILE MATERIALS | Engler Italia S.r.l. | VAN KREUNINGEN, KYRA MELOR | §103§112 | Non-Final OA | — | Pending | Feb 05, 2025 | |
| 18868253 | SOYBEAN PLANT CHARACTERIZED BY HIGH DROUGHT RESISTANCE | Sipcam Oxon S.p.A. | WILLIAMS, KEITH RICHARD | 1663 | §103§112 | Non-Final OA | — | Pending | Nov 22, 2024 |
| 18865784 | LACTICASEIBACILLUS PARACASEI DG(R) CNCM I-1572 DSM 34154 FOR USE IN A METHOD OF TREATING DYSBIOSIS IN PATIENTS WITH IBS | Alfasigma S.p.A. | GOUGH, TIFFANY MAUREEN | §102§112DP | Non-Final OA | — | Pending | Nov 14, 2024 | |
| 18863428 | CONFECTIONERY PRODUCT RESISTANT TO HIGH TEMPERATURES | Perfetti Van Melle S.p.A. | BEKKER, KELLY JO | §103§112 | Non-Final OA | — | Pending | Nov 06, 2024 | |
| 18849545 | TOPICAL PHARMACEUTICAL COMPOSITION WITH ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY AND USES THEREOF | Glycores 2000 Srl | ALAOUIE, ALI MUSTAFA | §103§112 | Non-Final OA | — | Pending | Sep 23, 2024 | |
| 18841688 | COMPOSITIONS COMPRISING BUTYRIC ACID AND GLUCONIC ACID FOR THE TREATMENT OF DISORDERS AND SYNDROMES ASSOCIATED WITH INTESTINAL BARRIER DYSFUNCTIONS AND DYSBIOSIS | Difass International S.p.A. | MAYHEW, BRADLEY SCOTT | §103 | Non-Final OA | — | Pending | Aug 27, 2024 | |
| 18840081 | A PROCESS FOR THE PRODUCTION OF A SOYBEAN FLOUR HAVING A HIGH SOLUBILITY | La Sanfermese S.p.A. | LEFF, STEVEN N | 1792 | §103 | Non-Final OA | — | Pending | Aug 21, 2024 |
| 18835362 | QUERCETIN-BASED COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF OCULAR AFFECTIONS | Indena S.p.A. | RAO, SAVITHA M | §103DP | Non-Final OA | — | Pending | Aug 02, 2024 | |
| 18832515 | COMPOSITION CONTAINING NERO DI TROIA POMACE EXTRACT | Planbio Cosmetics Srl | HOLT, ANDRIAE M | 1614 | §103§112 | Non-Final OA | — | Pending | Jul 24, 2024 |
| 18721678 | METHOD FOR THE PREPARATION OF HYBRID POLYMERIC NANOPARTICLES FOR THE RELEASE OF OLIGONUCLEOTIDE DRUGS IN PHARMACOLOGICAL THERAPIES FOR REGENERATIVE, CURATIVE, AND PREVENTIVE PURPOSES | UNIVERSITA' DEGLI STUDI DI TORINO | ARNOLD, ERNST V | 1613 | §103 | Non-Final OA | — | Pending | Jun 19, 2024 |
| 18719160 | PROBIOTIC COMPOSITIONS AND THEIR USE IN MODULATING ALLERGY-TYPE INFLAMMATORY ACTIVITY | Synbalance Srl | CELSA, BENNETT M | 1651 | §103§112 | Final Rejection | 20d | Pending | Jun 12, 2024 |
| 18666909 | LENTIL PASTA AND METHOD FOR ITS PREPARATION | Andriani S.p.A. | O'HERN, BRENT T | 1793 | §103 | Non-Final OA | — | Pending | May 17, 2024 |
| 18703377 | IMPROVED PROCESS FOR PROCESSING BIOLOGICAL SAMPLES | Diapath S.p.A. | SIMMONS, VALERIE MICHELLE | §103§112 | Non-Final OA | — | Pending | Apr 22, 2024 | |
| 18700010 | DETERGENT COMPOSITION FOR INTERNAL PARTS OF VEHICLES | Ma-Fra S.p.A. | GOLIGHTLY, ERIC WAYNE | 1714 | §103 | Final Rejection | 26d overdue | Pending | Apr 10, 2024 |
| 18616250 | METHYLENE BLUE HAVING A REDUCED CONTENT OF N-NITROSO-AZURE B IMPURITY AND PROCESS FOR OBTAINING THE SAME | Icrom S.r.l. | YOUNGBLOOD, WILLIAM JUSTIN | 1629 | DP | Final Rejection | — | Pending | Mar 26, 2024 |
| 18695504 | PROCESS FOR THE PREPARATION OF TAXANE DERIVATIVES | Indena S.p.A. | KOSAR, ANDREW D | 1625 | §103§112 | Non-Final OA | — | Pending | Mar 26, 2024 |
| 18596842 | POLYAMINOMETHYLENE PHOSPHONATE DERIVATIVES WITH LOW PHOSPHOROUS CONTENT HAVING SEQUESTERING AND DISPERSING PROPERTIES, RELATED USES AND PROCESSES FOR THE PREPARATION THEREOF | Giovanni Bozzetto S.p.A. | RHOADES, DEREK JAMES | §102§103§112 | Non-Final OA | — | Pending | Mar 06, 2024 | |
| 18687442 | METHOD FOR INCORPORATING FAT-SOLUBLE INGREDIENT INTO COMESTIBLE PRODUCT, AND PRODUCT RESULTING THEREFROM | Perfetti Van Melle Benelux BV | BEKKER, KELLY JO | 1792 | §102§112 | Non-Final OA | — | Pending | Feb 28, 2024 |
| 18681534 | BIOMIMETIC PEPTIDES AND THEIR USE IN BONE REGENERATION | Silk Biomaterials S.r.l. | BORGEEST, CHRISTINA M | §101§112 | Non-Final OA | — | Pending | Feb 06, 2024 | |
| 18681188 | PLATELETS TRANSFECTED WITH SIRNA AND THE THERAPEUTICS USES THEREOF | Plasfer S.r.l. | LIPPOLIS, ALEXANDRA ROSE | 1653 | §103§112 | Non-Final OA | — | Pending | Feb 05, 2024 |
| 18290888 | PHARMACEUTICAL OR FODD SUPPLEMENT FORMULATION CONTAINING ALPHA-LACTALBUMIN AND BUTYRIC ACID OR A SALT THEREOF | Kolfarma S.r.l. | TRUONG, QUANGLONG N | §103 | Non-Final OA | — | Pending | Jan 22, 2024 | |
| 18580851 | PROCESSES FOR THE PREPARATION OF ESTETROL AND INTERMEDIATES THEREOF | Newchem S.p.A. | CHENG, KAREN | 1623 | §112 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18579109 | METHOD FOR EVALUATING RESIDUAL PLATELET THROMBOTIC POTENTIAL IN PATIENTS UNDERGOING ANTIPLATELET TREATMENT | UNIVERSITA' DEGLI STUDI DI MILANO | WALLENHORST, MAUREEN | §101§103§112 | Non-Final OA | — | Pending | Jan 12, 2024 | |
| 18579158 | USE OF LACTOBACILLUS PARACASEI BACTERIAL STRAINS IN THE TREATMENT OF NEWBORNS | Alfasigma S.p.A. | CHHAY, BONIRATH | 1645 | §103§112DP | Final Rejection | 2d overdue | Pending | Jan 12, 2024 |
| 18577345 | NEW SYSTEMS FOR PRODUCING RECOMBINANT PROTEINS | Nemysis Limited | CHOWDHURY, IQBAL HOSSAIN | 1656 | §112Other | Non-Final OA | — | Pending | Jan 08, 2024 |
| 18576132 | STAINING COMPOSITIONS FOR BIOLOGICAL, CYTOLOGICAL, HISTOLOGICAL AND AUTOPSICAL SAMPLES | Diapath S.p.A. | KASS, BENJAMIN JOSEPH | §102§103§112 | Non-Final OA | — | Pending | Jan 03, 2024 | |
| 18565715 | OILY FORMULATIONS OF CANNABINOIDS | VELLEJA RESEARCH S.R.L. | BOECKELMAN, JACOB A | 1655 | §103 | Final Rejection | — | Pending | Nov 30, 2023 |
| 18561818 | FILLER FOR POLYMERIC COMPOSITIONS DERIVED FROM CITRUS PROCESSING AND/OR PRESSING WASTE | Krill Design Srl | POLLEY, CHRISTOPHER M | 1785 | §103 | Final Rejection | 61d | Pending | Nov 17, 2023 |
| 18560254 | MIXTURES OF POLYSACCHARIDES AND POLYAMINOSACCHARIDES WITH IMPROVED RHEOLOGICAL PROPERTIES | Jointherapeutics S.r.l. | OLSON, ANDREA STEFFEL | 1693 | §103Other | Final Rejection | — | Pending | Nov 10, 2023 |
| 18558810 | NLRP3 INFLAMMASOME-INHIBITING COMPOUNDS AND THE USE THEREOF | UNIVERSITA' DI PISA (40%) | HERNANDEZ, JACKSON J | 1627 | §103§112 | Final Rejection | 29d | Pending | Nov 03, 2023 |
| 18288361 | PROBIOTIC COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF METABOLIC SYNDROME AND RELATED DISORDERS | Synbalance Srl | FAN, LYNN Y | 1759 | §103§112 | Non-Final OA | — | Pending | Oct 25, 2023 |
| 18493221 | USE OF A COMPOSITION COMPRISING MICROORGANISMS TO INCREASE THE INTESTINAL PRODUCTION OF BUTYRIC ACID, FOLIC ACID OR NIACIN AND/OR DECREASE THE INTESTINAL PRODUCTION OF SUCCINIC ACID | Alfasigma S.p.A. | XU, QING | 1656 | §103 | Final Rejection | 63d | Pending | Oct 24, 2023 |
| 18556691 | FUSION PROTEINS AND USE THEREOF IN THE TREATMENT OF MEMBRANOUS NEPHROPATHY | Kilometro Rosso Spa | MCCOLLUM, ANDREA K | 1674 | §103§112 | Non-Final OA | — | Pending | Oct 23, 2023 |
| 18552694 | DIGITAL INKJET PRINTING PRIMER FOR PLASTIC FILMS FOR FOOD PACKAGING | Goglio S.p.A. | HON, SOW FUN | 1782 | §103 | Non-Final OA | 40d | Pending | Sep 27, 2023 |
| 18546065 | SOLID COMPOSITION OF INDOCYANINE GREEN AND SODIUM FLUORESCEIN | Icrom Srl | LEWOCZKO, EVAN MICHAEL | 1612 | §103 | Final Rejection | 30d | Pending | Aug 10, 2023 |
| 18254864 | SOLUBLE POLYELECTROLYITIC COMPLEXES OF POLYMERIC BIGUANIDINE MICROBIOCIDES WITH GLYCOSAMINOGLYCANS | Altergon S.A. | LIU, TRACY | 1614 | §103§112 | Final Rejection | 41d | Pending | May 29, 2023 |
| 18039204 | USE OF MULTI-SPECIFIC HUMAN ALBUMIN NANOPARTICLES DECORATED WITH ANTIBODY FRAGMENTS AND LOADED WITH CYTOTOXICS | Anbition S.r.l. | HAM, JIEUN | 1643 | §103§112DP | Non-Final OA | — | Pending | May 26, 2023 |
| 18246607 | RECOMBINANT YEAST FOR THE PRODUCTION OF OLIGOPEPTIDE | Lesaffre Et Compagnie | NOAKES, SUZANNE MARIE | 1656 | §103§112 | Final Rejection | 18d overdue | Pending | Mar 24, 2023 |
| 18040525 | RETANNING AND FATLIQUORING COMPOSITIONS COMPRISING A HEMP OIL DERIVATIVE | UNIQUE S.R.L. | KHAN, AMINA S | 1761 | §103§112 | Final Rejection | 46d overdue | Pending | Feb 03, 2023 |
| 17999906 | AQUEOUS DESINFECTANT COMPOSITION FOR GLASSES | Unifarco S.p.A. | WISTNER, SARAH CLINKSCALES | 1616 | §112 | Final Rejection | 23d | Pending | Nov 25, 2022 |
| 17998534 | COMPOSITION COMPRISING METHYLFOLATE | Alfasigma S.p.A. | KASSA, TIGABU | 1619 | §103§112 | Non-Final OA | — | Pending | Nov 11, 2022 |
| 17905646 | BLOOD PREPARATION USEFUL FOR WOUND HEALING AND TISSUE REGENERATION | Novystem S.p.A. | MELLER, MICHAEL V | 1655 | §103§112 | Final Rejection | 78d overdue | Pending | Sep 05, 2022 |
| 17904895 | HYBRID COSMETIC PRODUCT CONSISTING OF CREAMY COMPACT POWDER | Art Cosmetics S.R.L. | OLSEN, KAELEIGH ELIZABETH | 1619 | §103§112 | Non-Final OA | 78d overdue | Pending | Aug 24, 2022 |
| 17798218 | BIO-BASED BINDERS AND METHODS FOR PRODUCING SAME | Agroils Technologies S.p.A. | TOLIN, MICHAEL A | 1745 | §103§112 | Final Rejection | 13d | Pending | Aug 08, 2022 |
| 17757453 | INJECTABLE MIXTURES OF HYALURONIC ACID FOR USE IN DERMO-AESTHETICS | Altergon S.A. | KRISHNAN, GANAPATHY | 1693 | §103DP | Final Rejection | 17d overdue | Pending | Jun 16, 2022 |
| 17757455 | SYNOVIAL FLUID SUBSTITUTES | Altergon S.A. | WAX, ROBERT A | 1615 | §102§103 | Final Rejection | 7d | Pending | Jun 16, 2022 |
| 17754150 | HYDROGEL BASED ON ZINC GLUCONATE AND HYALURONIC ACID ESTERS | BMG PHARMA S.P.A. | PIPIC, ALMA | 1617 | §103 | Non-Final OA | 34d | Pending | Mar 25, 2022 |
| 17632841 | CHOLECALCIFEROL FOR USE IN THE TREATMENT OF CELIAC DISEASE | Abiogen Pharma S.p.A. | MCMILLIAN, KARA RENITA | 1623 | §103 | Non-Final OA | 46d overdue | Pending | Feb 04, 2022 |
| 17628578 | PROCESS FOR THE PREPARATION OF AMORPHOUS MIDOSTAURIN WITH A LOW CONTENT OF RESIDUAL ORGANIC SOLVENT | Procos S.p.A. | ADLAM, CHANTAL PETA-GAYE | 1622 | §103 | Non-Final OA | 30d | Pending | Jan 20, 2022 |
| 17609416 | FERTILIZING COMPOSITION COMPRISING A GLASS MATRIX | Mpd S.r.l. | SILVA RAINBOW, HEATHER ELISE | 1731 | §103§112 | Final Rejection | 42d overdue | Pending | Nov 08, 2021 |
| 17295722 | MULTI-LAYERED PARTICLES | Sphera Encapsulation Srl | HOERNER, PAUL ELLSWORTH | 1611 | §103DP | Final Rejection | — | Pending | May 20, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial